UNSPSC 51141514: Zonisamide

This classification denotes an anticonvulsant agent with the molecular formula C8H8N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 459384H98V, chemically known as 1,2-benzisoxazole-3-methanesulfonamide but generally known as zonisamide, which bears US NIH Compound Identifier 5734. European Medicines Agency schedules Zonisamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00187MIG.

UNSPSC 51141514 Zonisamide is a Commodity code that maps to pharmaceutical products, though the recent state and local activity under this code does not align with zonisamide procurement itself. The single recent opportunity tagged to this code is Seminole County, Florida's IFB for naloxone and drug deactivation systems, a community health initiative unrelated to zonisamide (an anticonvulsant medication). This mismatch suggests either a tagging error in the state procurement system or that the code is used more broadly for emergency response pharmaceuticals and medical supplies than its nominal commodity name reflects. The work being solicited is the supply of naloxone (opioid antagonist) and drug deactivation systems on a recurring annual basis, delivered quarterly to a designated county health facility, with full responsibility for shipping and logistics falling to the vendor.

The Seminole County opportunity represents the only recent activity visible under this code. The procurement issued an IFB on June 30, 2026, with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually under a two-year initial contract with one-year renewal option. The county requires electronic bid submission through its e-Procurement Portal, unit pricing for each line item, drug-free workplace certification, E-Verify compliance, and standard insurance coverage (workers' compensation, commercial general liability, and professional liability). The contract includes a three-month probationary period allowing termination at will. No explicit set-aside or disadvantaged-enterprise designations are stated. The procurement may be FEMA-funded, which introduces compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.